Custom service

Peptidomimetics Service

Convert peptide hits into peptidomimetics with better stability and permeability

Turnaround: 5–9 weeksTypical scale: 0.1 mg – 10 g per sequenceChemistry options: β-peptide and γ-peptide turn mimics; azapeptide and retro-inverso designs; scaffold hopping from peptide pharmacophores

The service is built around β-peptide and γ-peptide turn mimics. Depending on the molecule we may move to azapeptide and retro-inverso designs or scaffold hopping from peptide pharmacophores to improve stability, loading or yield, and every batch is released with peptidomimetic candidates with design rationale.

Because Peptidomimetics projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.

Converting labile peptide hits

Improving oral-relevant properties

Full small-molecule medicinal chemistry programmes

Sequences where a recombinant expression route is objectively cheaper and faster

Release specification is fixed at quotation: standard >95% by HPLC, >98% for assay-critical material. Long chains (>60 residues) are additionally confirmed by MS/MS sequence coverage, and truncated-deletion species are quantified, not just summarized.

Service Highlights

  • Β-peptide and γ-peptide turn mimics as the default route, with azapeptide and retro-inverso designs held as a proven fallback
  • Scaffold hopping from peptide pharmacophores worked into the design where the application requires it
  • Sequence difficulty analysis (aggregation risk, motif hazards) is done before synthesis, and the route is chosen around it
  • Analytical confirmation of every intermediate before the final release
  • Microwave-assisted coupling and double-coupling are applied automatically where the sequence demands them
  • Peptidomimetic candidates with design rationale delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Sequence analysis

    Peptidomimetics Service is analyzed for aggregation risk, motif hazards and puri?cation difficulty before a route is quoted.

  2. Route selection

    Fmoc solid-phase, fragment ligation or hybrid solution-phase is selected and documented.

  3. Assembly

    The chain is built with β-peptide and γ-peptide turn mimics applied where the sequence demands it, with double-coupling at hazard sites.

  4. Cleavage & crude QC

    Crude material is characterized so purification targets are set on data, not hope.

  5. Purification

    RP-HPLC (and ion-exchange where needed) delivers the agreed purity; fractions are pooled on MS confirmation.

  6. Release

    Peptidomimetic candidates with design rationale is documented with the full analytical package and released.

Specifications & timeline

Turnaround
5–9 weeks
Typical scale
0.1 mg – 10 g per sequence
Chemistry options
β-peptide and γ-peptide turn mimics; azapeptide and retro-inverso designs; scaffold hopping from peptide pharmacophores
Deliverable
Peptidomimetic candidates with design rationale
QC package
HPLC purity, ESI/MALDI MS, MS/MS confirmation for long chains
Shipping
Ambient with desiccant; blue ice for modified or sensitive peptides

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.